Premarket Mover: Collegium Pharmaceutical Inc (COLL) Down 12.07%

Tuesday, February 07, 2023 06:56 AM | InvestorsObserver Analysts

Collegium Pharmaceutical Inc (COLL) is lower by Tuesday morning, with the stock falling -12.07% in pre-market trading to 24.4. COLL's short-term technical score of 93 indicates that the stock has traded more bullishly over the last month than 93% of stocks on the market. In the Drug Manufacturers - Specialty & Generic industry, which ranks 141 out of 146 industries, the stock ranks higher than 94% of stocks. Collegium Pharmaceutical Inc has fallen 3.14% over the past month, closing at $28.45 on January 10. During this period of time, the stock fell as low as $27.38 and as high as $30.22. COLL has an average analyst recommendation of Strong Buy. The company has an average price target of $32.25.

COLL has an Overall Score of 76. Find out what this means to you and get the rest of the rankings on COLL!
Collegium Pharmaceutical Inc has a Long-Term Technical rank of 97. This means that trading over the last 200 trading days has placed the company in the upper half of stocks with 3% of the market scoring higher. In the Drug Manufacturers - Specialty & Generic industry which is number 143 by this metric, COLL ranks better than 143% of stocks.

Important Dates for Investors in COLL:

-Collegium Pharmaceutical Inc is set to release earnings on 2/23/2023. Over the last 12 months, the company has reported EPS of $-1.09. -We do not have a set dividend date for Collegium Pharmaceutical Inc at this time. Click Here To Get The Full Report on Collegium Pharmaceutical Inc (COLL)

Share this article: